Psychedelics M&A heating up as one drug nears FDA-approval
With MDMA on track to gain United States Food and Drug Administration (FDA) approval for the treatment of post-traumatic stress disorder (PTSD) in 2024, Big...
Stay updated with breaking news from Small Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With MDMA on track to gain United States Food and Drug Administration (FDA) approval for the treatment of post-traumatic stress disorder (PTSD) in 2024, Big...
• Results suggest that SSRIs enhance the efficacy of SPL026 when administered to MDD patients on a stable dose of SSRIs versus patients not on SSRIs • At Week 4, 100% of patients in the SSRI...
• Results suggest that SSRIs enhance the efficacy of SPL026 (DMT) when administered to MDD patients on a stable dose of SSRIs versus patients not on SSRIs
• Results suggest that SSRIs enhance the efficacy of SPL026 (DMT) when administered to MDD patients on a stable dose of SSRIs versus patients not on SSRIs ...
Filament Health Corp (OTCQB:FLHLF)'s diversified business model makes it one of the only psychedelics companies to be already generating revenue. The...